DMAAU

Drugs Made In America Acquisition Corp. Units

Insider Trades

Name	Value	Action	Price	Current Price
Drugs Made In America Acquisition LLC10 Percent Owner Disclosure amount unavailable30k shares BuyFeb 18, 2025 -- --
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Exe. Chair Of Board Disclosure amount unavailable30k shares BuyFeb 18, 2025 -- --
Drugs Made In America Acquisition LLC10 Percent Owner $8.5M5.7M shares SellJan 29, 2025 $1.50 --
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Executive COB $8.5M5.7M shares SellJan 29, 2025 $1.50 --
Drugs Made In America Acquisition LLC10 Percent Owner Disclosure amount unavailable400k shares BuyJan 29, 2025 -- --
Stockwell LynnDirector, 10 Percent Owner, Officer: CEO And Executive COB Disclosure amount unavailable400k shares BuyJan 29, 2025 -- --

Trade DMAAU

About Drugs Made In America Acquisition Corp. Units

Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.

CEO: Roger Bendelac
IPO Date: Jan 27, 2025

Market Data

Open: $10.69
High: $10.69
Low: $10.61
Volume: 2.1K
Avg Volume: 659
52W High: $12.50
52W Low: $10.30

Valuation

Market Cap: $360M
Enterprise Value: $358M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-539k
Revenue: $0
Net Income: $5.9M
Cash: $6.1k
Debt: $0

Events

IPOJan 27

NASDAQ